# Medications Development Clinical Trials Network for the Treatment of Alcohol Use Disorder - Contract Research Organization

> **NIH NIH N01** · FAST TRACK DRUGS AND BIOL · 2021 · $1,967,405

## Abstract

Medications development is a high priority program at National Institute on Alcohol Abuse and Alcoholism (NIAAA). Currently, only three medications are approved by the Food and Drug Administration (FDA) for the treatment of alcohol use disorder (AUD). These medications have demonstrated small to moderate effect sizes in clinical trials and do not work for everyone, making the search for new molecular targets and more efficacious pharmacotherapies critical.  The purpose of the current contract is to support a Contract Research Organization (CRO) to conduct all aspects of multiple, multi-center, pharmacotherapy clinical trials for the treatment of AUD.

## Key facts

- **NIH application ID:** 10506189
- **Project number:** 75N94019D00001-0-759402100002-1
- **Recipient organization:** FAST TRACK DRUGS AND BIOL
- **Principal Investigator:** JANET RANSOM
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,967,405
- **Award type:** —
- **Project period:** 2021-06-11 → 2023-06-10

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10506189

## Citation

> US National Institutes of Health, RePORTER application 10506189, Medications Development Clinical Trials Network for the Treatment of Alcohol Use Disorder - Contract Research Organization (75N94019D00001-0-759402100002-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10506189. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*